| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ec49572b35adc4d2ed59562a84f7d01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d5b0121795696aff39ff79ed882fa6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cfd8220c7a51a28e11e77e6c63dfa0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad43cb25ea0aab52a45742642ebaec01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0022f6f6d5d821b82ca7693766010bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate |
1999-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33a3ccc0b3f3bb0e136666ab39034599
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13d99f7e486c7040c29bb39661721df6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a1801bf8403afb03ec179ffebe72128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4620ca9d568f8ae79f8f51b85038cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_097dbd7bad20157e0b5a43ee4d5f4de7 |
| publicationDate |
2000-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0029019-A1 |
| titleOfInvention |
Restoration of platelet aggregation by antibody administration after gpiib/iiia antagonist treatment |
| abstract |
The invention provides a process to restore platelet aggregation by the administration of antibody combining site-containing molecules that specifically bind to a specific class of reversibly-bound GPIIb/IIIa fibrinogen receptor antagonist compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7812038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2384766-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011138279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2269630-A1 |
| priorityDate |
1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |